Clinical Trial Update: Xience/Promus for Long Coronary Lesion Registry [Phase 4]

View source ↗

Summary

This is a Phase 4 registry update evaluating Xience and Promus drug-eluting stents for long coronary artery disease. The current status of the registry is not d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Promus (sirolimus-eluting stent)
• Xience (everolimus-eluting stent with permanent polymer)

Snippet

Sponsor: Society for Advancement of Coronary Intervention Research | Conditions: Long Coronary Artery Disease | Phase 4 | Status: UNKNOWN